Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Gabapentin Related compound A/ 4,4-Pentamethylene-2-pyrrolidone

Gabapentin Related compound A/ 4,4-Pentamethylene-2-pyrrolidone

64744-50-9

DISCOVER
Gabapentin USP

Gabapentin USP

60142-96-3

DISCOVER
Griseofulvin

Griseofulvin

126-07-8

DISCOVER
Guanine USP

Guanine USP

73-40-5

DISCOVER
GUAIFENESIN CRS (130 MG)

GUAIFENESIN CRS (130 MG)

93-14-1

DISCOVER
Glimepiride Related Compound B

Glimepiride Related Compound B

119018-29-0

DISCOVER
(+)-Garcinia acid

(+)-Garcinia acid

27750-13-6

DISCOVER
Genistein

Genistein

446-72-0

DISCOVER
Gefitinib

Gefitinib

184475-35-2

DISCOVER
Glimepiride

Glimepiride

93479-97-1

DISCOVER
Glibenclamide

Glibenclamide

10238-21-8

DISCOVER
Gibberellin A4

Gibberellin A4

468-44-0

DISCOVER